{"id":122101,"date":"2026-03-03T00:01:36","date_gmt":"2026-03-03T00:01:36","guid":{"rendered":"https:\/\/www.atlasrleye.com\/proliferative-diabetic-retinopathy-in-type-1-diabetes\/clinical-case-13\/"},"modified":"2026-03-03T02:56:34","modified_gmt":"2026-03-03T02:56:34","slug":"clinical-case-13-1","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/proliferative-diabetic-retinopathy-in-type-1-diabetes\/clinical-case-13-1\/","title":{"rendered":"Clinical Case 13"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Retinopatia%20Diab%C3%A9tica|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” add_icon=”true” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 1 Diabetes – Clinical Case 13″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” css=”” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-1-diabetes%2F|title:RETINOPATIA%20DIAB%C3%89TICA%20PROLIFERATIVA%20TIPO%20I|”]

<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”120789″ img_size=”280×230″ alignment=”center” onclick=”link_image” css=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Fluorescein angiography image from a 25-year-old patient with diabetic retinopathy, diagnosed with diabetes at 2 years of age. HbA1c=8,6%. BCVA: 20\/25 RE, 20\/50 LE. <\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”120969″ img_size=”280×230″ alignment=”center” onclick=”link_image” css=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Patient with an insulin pump.Intravitreal anti-angiogenic agents were used in an attempt to reduce the need for laser treatment.BCVA: 20\/20 RE; 20\/20 LE. BCVA: 20\/20 RE; 20\/20 LE.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 06 01 2015″ tab_id=”1671731979894-a1c6e53a-7f91″][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Diabetic retinopathy. Many hyperfluorescent dots (microaneurisms),leakage and hypoflorescent areas.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120817,120821,120865,120869″ img_size=”180×180″ css=”.vc_custom_1772494316959{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120857,120861″ img_size=”180×180″ css=””][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120801,120805″ img_size=”180×180″ css=””][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text css=””]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120809,120813″ img_size=”180×180″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120841,120845″ img_size=”220×220″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

Diabetic retinopathy. 25-year-old patient, diagnosed with diabetes at 2 years of age. HbA1c=8,6%. BCVA: 20\/25 RE, 20\/50 LE. <\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120849,120853,120793,120797″ img_size=”220×220″ css=”.vc_custom_1772494689810{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120825,120829,120833,120837″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – 25 10 2016″ tab_id=”1772494767888-2a34fa85-2a45″][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Proliferative Diabetic Retinopathy (NVE).<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120893,120901,120909,120937,120945″ img_size=”180×180″ css=”.vc_custom_1772494934572{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120953,120957″ img_size=”180×180″ css=””][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120917,120925″ img_size=”180×180″ css=””][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text css=””]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120929,120933″ img_size=”180×180″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

Note the laser photocoagulation scars.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120941,120949,120885,120889″ img_size=”220×220″ css=”.vc_custom_1772499132103{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120897,120905,120913,120921″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – 06 11 2025″ tab_id=”1772494828715-9009e37f-e4e2″][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”121037,121041,121005,121009″ img_size=”180×180″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”121029,121033″ img_size=”180×180″ css=””][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120973,120977″ img_size=”180×180″ css=””][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text css=””]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120981,120985″ img_size=”180×180″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”121013,121017″ img_size=”220×220″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

Patient with an insulin pump. Anti-angiogenic agents were used in an attempt to reduce the need for laser treatment. <\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”121021,121025″ img_size=”220×220″ css=”.vc_custom_1772495638577{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

BCVA: 20\/20 RE; 20\/20 LE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”120989,120993,120997,121001″ img_size=”307×110″ css=”.vc_custom_1772496061620{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Retinopatia%20Diab%C3%A9tica|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” add_icon=”true” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 1 Diabetes – Clinical Case 13″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” css=”” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-1-diabetes%2F|title:RETINOPATIA%20DIAB%C3%89TICA%20PROLIFERATIVA%20TIPO%20I|”][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”120789″ img_size=”280×230″ […]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":75353,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-122101","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/122101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=122101"}],"version-history":[{"count":6,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/122101\/revisions"}],"predecessor-version":[{"id":122109,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/122101\/revisions\/122109"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75353"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=122101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}